Selective serotonin reuptake inhibitors (SSRIs) for treatment of COPD

This technology is a mesh scaffold capable of growing probiotic strains against respiratory pathogens that can be used for the prevention and treatment of Chronic Obstructive Pulmonary Disease (COPD).

Probiotic prevention of COPD and other respiratory diseases.

Addresses disease progression of COPD.

The Technology: Exogenous Rac1 analogs for protection against acute lung injury.

In the lungs, prolonged inflammation from infection leads to acute lung injury (ALI), which can result in acute respiratory distress syndrome (ARDS), a condition that is associated with high mortality.

Prevention of lung injury in donor lungs during transplantation.

Unmet Need: Non-invasive method for the diagnosis of COPD.

Early diagnosis of other lung diseases.

Monitoring of disease progression in COPD or other lung diseases.